# Trade Mark Journal No.2026/012 20 March 2026

## WO0000001905502 (5)

Office of origin: United States of America

Date of International Registration:4 February 2026
Date of designation in the UK: 4 February 2026

International priority date claimed: 6 August 2025 (United States of America) (99323836)

Class 5
  Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.

Amylyx Pharmaceuticals, Inc.

Representative: Fish & Richardson P.C., PO Box 1022, Minneapolis MN 55440-1022, UNITED STATES OF AMERICA